About NGALTest.co.uk

About-NGALTest-1

NGALTest.co.uk is a website that is dedicated to raising awareness amongst Researchers, Drug Developers and Clinicians about the potential uses of the biomarker Neutrophil Gelatinase-associated Lipocalin (NGAL), also known as Lipocalin-2.

NGAL has considerable potential as a prognostic and diagnostic tool for a variety of disease states. This website provides further information about NGAL and the range of assays and reagents available to facilitate both its use as a biomarker and research into its biological role.

Alpha Laboratories Ltd

This website is owned and run by Alpha Laboratories Limited, who are proud advocates of NGAL as tool to enhance human health. You can read more about Alpha Laboratories here. You can also visit our main website here:

Visit the Alpha Laboratories Website

 

BioPorto Diagnostics A/S

Alpha Laboratories are partners and distributors for BioPorto Diagnostics, Denmark. BioPorto  are widely recognised as specialists in the development and manufacturing of NGAL assays and associated products and applications.

Visit the BioPorto Diagnostics Website

 

PLEASE NOTE: The information on this site is not designed primarily for use by the general public. Similarly the products are not suitable for personal purchase and self-testing.

 

If you have any concerns about any of the diseases or conditions described on this site, please speak to your GP.

 

If you would like further reading, please use the links that are in the bottom right corner of every page on this site.

About the NGAL Assay

Although NGAL is best known as being a biomarker of acute kidney injury (AKI), and is proving to be of great value in drug development in this context, it is now being implicated in as a key component of a number of other pathways and disease states. These include cancer, inflammation and sepsis.

Our sensitive and reliable ELISA based NGAL assays provide a reliable and sensitive means of measuring NGAL levels in both pharmaceutical and medical research settings.

Read More